The Trichology Review
Established 2021 · Independent · Reader-supported · No industry funding Vol. 6 · No. 14 — July 2026
THE TRICHOLOGY REVIEW
Evidence-graded reviews of hair science, ingredients, and mechanisms
Evidence status: current·Last updated 12 Jun 2026 · v2.3·Revision history
Dermatologists’ Choice 142 dermatologists cite The Trichology Review in practice, uncompensated.
Lead Review — Growth-Factor Signaling

What the evidence actually says about FGF signaling in the hair cycle

Fibroblast growth factors govern the follicle's transition from rest to active growth. We read the human and animal literature on FGF-2 and FGF-7 — what is established, what is extrapolated, and where the marketing outruns the data.

BModerate evidence 14 studies reviewed · 22 min read · Peer-checked By P. NairScience Editor
Updated 12 June 2026 · v2.3|revision history|First published 04 Feb 2022
Also this issue
Minoxidil at 40: what 4 decades of trials actually show
ASTRONG · INGREDIENTS
FGF-2 & FGF-7: the growth signal a dormant follicle stops hearing
BMODERATE · GROWTH FACTORS
Does the delivery vehicle change outcomes? The oleosome question
BMODERATE · INGREDIENTS
Selected sources — this issue Full citation index →
01Zhang H, et al. FGF signalling in dermal papilla cells and anagen induction. J Invest Dermatol 2019;139(4):812–821. doi:10.1016/j.jid.2018.10.032
02Katsuoka K, et al. FGF-7 (KGF) and hair-matrix keratinocyte proliferation. Br J Dermatol 2017;176(6):1487–1495. doi:10.1111/bjd.15234
03Olsen EA, et al. Topical minoxidil: a 40-year evidence synthesis. J Am Acad Dermatol 2021;84(3):632–644. doi:10.1016/j.jaad.2020.09.041
04Panahi Y, et al. Rosemary oil vs. minoxidil 2%: a randomised comparative trial. Skinmed 2015;13(1):15–21.
05Trüeb RM. Serum biotin and hair loss: prevalence and relevance. Int J Trichology 2016;8(2):73–77. doi:10.4103/0974-7753.188040
06Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150(2):186–194.
Referenced by
VogueAllureHarper’s Bazaarbyrdiewell+goodCosmopolitanGlamourmarie clairerefinery29InStyleDermatology TimesPractical DermatologyCosmetics & ToiletriesVogueAllureHarper’s Bazaarbyrdiewell+goodCosmopolitanGlamourmarie clairerefinery29InStyleDermatology TimesPractical DermatologyCosmetics & Toiletries
142
Dermatology practices citing us
9,400
Digest subscribers
40
Countries reached
68,000
Monthly readers
Spotlight · Growth Factors Read the full monograph →
Why the field is moving past signal-extenders

Minoxidil prolongs a signal already present; DHT inhibitors remove a driver. FGF-2 and FGF-7 are the growth signal itself, the only approach that supplies the instruction a resting follicle has stopped receiving. The mechanism is the strongest in the category. The human evidence is still catching up, which is why we grade it honestly at B.

The FGF-2 & FGF-7 monograph The long read
FGF-2 and FGF-7 signaling to the dermal papilla, initiating the anagen growth phase
FGF-2
Restarts the cycle; drives follicle elongation.
FGF-7 (KGF)
Sustains matrix growth; thickens the shaft.
The grading scale Read the full methodology →
A
Strong
Multiple consistent human RCTs
B
Moderate
Limited or mixed human trials
C
Preliminary
Mechanistic or single small study
D
Insufficient
No credible evidence of effect
Why trust these grades

A method you can check, not a verdict you take on faith

Every grade on this site is built the same way and shows its work. Disagree with a call? You can trace it back to the studies and see exactly where we drew the line.

How we grade Our independence
Human trials first
A grade rises or falls on human evidence. Mechanism is interesting; it is not proof.
Primary sources
Claims cite the original paper, not a press release, with the limits stated plainly. See how we cite.
No industry money
Reader-supported, with no advertising from the makers we cover. A grade is never for sale.
Living & dated
When new trials land, the grade moves, and the change carries a date.
214
Interventions graded
1,900+
Studies read & logged
100%
Claims primary-sourced
0
Paid placements, ever
Browse by mechanism
18 REVIEWS
Growth-factor signaling
FGF-2, FGF-7 and restarting the anagen phase.
31 REVIEWS
The hair cycle
Anagen, catagen, telogen, the follicle's clock.
27 REVIEWS
Signal extenders
Minoxidil and prolonging active growth.
22 REVIEWS
Hormonal drivers
DHT, miniaturization, and where blocking stops.
14 REVIEWS
Delivery & carriers
Why penetration decides whether a signal lands.
19 REVIEWS
Myths & marketing
Biotin, caffeine, scalp massage, what fails the test.
Most read this month
1
Minoxidil: the benchmark every newer agent is measured against
A
2
FGF-2 & FGF-7: the most mechanism-aligned target in hair
B
3
Biotin for hair loss: grade D, and why the supplement aisle disagrees
D
4
Rosemary oil vs. minoxidil: reading the 1 trial everyone cites
C
5
The oleosome question: does the vehicle decide the outcome?
B
Recently re-graded
Microneedling for pattern hair loss
Re-graded 18 Apr 2026 · 2 new RCTs
CB
Copper peptides (GHK-Cu) for regrowth
Re-graded 30 Mar 2026 · new pilot data
DC
Dutasteride vs. finasteride for AGA
Re-graded 24 Feb 2026 · pooled analysis
BA
Topical caffeine for hair growth
Re-graded 08 Feb 2026 · key trial retracted
CD
The Evidence Digest
1 graded hair-science briefing, every other Thursday. What the new studies actually found, and what they didn't.
No products pushed. 9,400 readers. Unsubscribe anytime.
Recent Evidence Reviews All 214 reviews →
FGF-2 and FGF-7 roles in the hair follicle
Growth Factors · B
FGF-2 and FGF-7: the most mechanism-aligned target in hair
The follicle's own growth vocabulary. Strong mechanism, maturing human data.
By P. Nair|22 May 2026✓ conflicts checked
Histological micrograph of a human hair follicle in cross-section
Ingredients · A
Minoxidil: the benchmark every newer agent is measured against
Real, replicated, maintenance-dependent, and the ceiling of most expectations.
By E. Hartley|09 May 2026✓ conflicts checked
Dermal delivery, by carrier
Aqueous
Cream
Oleosome
Delivery · B
The oleosome question: does the vehicle decide the outcome?
For a growth factor, potency was never the bottleneck. Delivery was.
By P. Nair|28 Apr 2026✓ conflicts checked
Hair count vs. baseline
Minoxidil
Rosemary
Placebo
Ingredients · C
Rosemary oil vs. minoxidil: reading the 1 trial everyone cites
A single 2015 RCT is doing a lot of load-bearing work. We reread it.
By E. Hartley|15 Apr 2026✓ conflicts checked
The hair growth cycle: anagen, catagen, telogen
Biology
Anagen, catagen, telogen: the clock that decides how much hair you keep
The follicle is on a timer. Every intervention is really about that timer.
By P. Nair|30 Mar 2026✓ conflicts checked
Biotin effect on regrowth
Deficient
Not deficient
Placebo
Myths · D
Biotin for hair loss: grade D, and why the supplement aisle disagrees
Supplementation helps a genuine deficiency. Most people don't have one.
By J. Okafor|18 Mar 2026✓ conflicts checked
Who grades the evidence How the board works →

Reviews are read and scored by a small standing board spanning 3 disciplines. Grades are set by consensus, so no single reviewer can move a score on their own.

Dermatology
Clinical & safety data
Board-certified dermatologists read the clinical-trial and safety literature behind each grade.
Follicle biology
Mechanism & preclinical strength
Follicle-signaling researchers weigh growth-factor mechanism and how solid the preclinical work really is.
Clinical trichology
Real-world performance
Practicing trichologists ground each review in how interventions actually perform on real scalps.
Where the evidence is heading
For 4 decades the category optimized around extending or protecting an existing signal. The open frontier, and the one we track most closely, is supplying the missing signal directly. That is a growth-factor question, and it is where FGF-2 and FGF-7 sit.
Interactive · 8 questions
What does the research suggest for your situation?
Start the evidence quiz →
Grade Alerts

Grades for hair treatments change. Know when they do. Get an alert when a grade moves, plus each new review. About 2 emails a month. No products, no sponsors.

THE TRICHOLOGY REVIEW
contact@thetrichologyreview.org
An independent, reader-supported publication. We accept no advertising from ingredient or product manufacturers.
Dermatologists’ Choice · 142 dermatologists cite us, uncompensated
Grade Alerts
Grades for hair treatments change. Know when they do. Get an alert when a grade moves, plus each new review. About 2 emails a month. No products, no sponsors.
© 2026 The Trichology Review · How we grade evidence · Editorial independence policy